EMA publishes new GDP non-compliance report for wholesaler in Norway
Recommendation
Tuesday, 29 September 2026 14.00 - 16.00 h
GDP-compliant Transport Processes: from Risk Assessment to Practical Implementation
On the Road to 30,000 Members
Let us become the World's Leading GMP/GDP Compliance Community in 2026
The European Database EudraGMDP doesn't only contain GMP, but also GDP reports of non-compliance. The Norwegian Authority has issued a statement of non-compliance with GDP for medicinal products of the company Norges NaturmedisinSentral AS, Terminalen 9, Bachetomta næringspark, Lierstranda industriområde, LIER, NO-3414, Norway.
The company was involved in the distribution of medicinal products requiring cold storage and transportation. These operations were not managed under GDP. As a consequence the WDA (Wholesale Distributor Authorisation) has been partly withdrawn. Cold chain activities are now no longer permitted.
Source: EudraGMDP Database (GDP Non-Compliance Report)
Related GMP News
10.09.2026Reminder: Submit your Presentation Proposal for the GDP Forum 2027 by 30 September
10.09.2026GDP in the US: FDA Launches DSCSA Assessment for Small Dispensers and Issues Exemptions
11.08.2026GDP for APIs: APIC Publishes Updated "How to Do" Document
11.08.2026Where to Find Information on UK Wholesale Authorisations
11.08.2026Call for Presentations: GDP Forum 2027 in Berlin
11.08.2026Questions and Answers from the ECA Webinar "GDP Update 2026" - Part 5